# AssureRx Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/assurerx-health

- Industry: Healthcare
- Headquarters: Mason, US
- Website: www.assurerxhealth.com
- Total disclosed funding: $25M
- Latest round: Series C (May 30, 2012)
- Investors on record: 10

## About

AssureRx Health Inc. develops personalized medicine solutions focused on pharmacogenomic testing and decision support tools to enhance treatment efficacy and minimize adverse drug reactions.AssureRx Health Inc. was founded in 2006 and is headquartered in Mason, US. The company specializes in personalized medicine solutions, providing pharmacogenomic testing and decision support tools. In August 2016, AssureRx was acquired by Myriad Genetics, Inc. for an initial USD 225 mn, with an additional USD 185 mn based on performance. The company has completed 12 deals as of 2016, which includes its latest round of funding, ADD-ON, led by Myriad Genetics, Inc. The founder's background details are not available.AssureRx Health specializes in personalized medicine solutions, focusing primarily on pharmacogenomic testing and decision support tools. The company's core offerings include genetic testing services that guide healthcare providers in selecting the most effective medications based on individual genetic profiles. This approach aims to enhance treatment efficacy and minimize adverse drug reactions, particularly in psychiatry and chronic pain management. AssureRx Health serves a broad client base that includes healthcare providers, hospitals, and insurance companies across the United States, as well as selected international markets, enabling physicians to improve patient outcomes through tailored medication strategies.AssureRx Health generates revenue primarily through its pharmacogenomic testing services, delivered via a business-to-business (B2B) model. Healthcare providers and institutions purchase testing services on a subscription basis, allowing effective integration into clinical practices. The revenue structure includes partnerships with insurance organizations that facilitate coverage for relevant testing procedures. Pricing tiers accommodate various service levels, including standalone tests and bundled services, which provide comprehensive genetic insights aligned with the company's focus on personalized medicine.AssureRx Health plans to expand into new geographic regions and markets, though specific locations have not been disclosed. The company intends to utilize recent funding to enhance its product offerings and market presence. Following the acquisition by Myriad Genetics, a significant portion of the USD 225 mn investment is expected to support these initiatives, focusing on the development of new products and services designed to improve patient care.

## Funding rounds

- Series C, May 30, 2012, $13M — Hong Shan, Claremont Creek Ventures, Alafi Capital, Allos Ventures, Four Rivers Group, CincyTech, jVen Capital, Mayo Clinic, Cincinnati Children's Hospital Medical Center
- Series B, Mar 25, 2011, $11M — Hong Shan, Claremont Creek Ventures, Allos Ventures, CincyTech, Mayo Clinic, Cincinnati Children's Hospital Medical Center
- Series A, Jun 15, 2008, $1.6M — Rev1 Ventures

## Investors

- Rev1 Ventures (https://capitalatlas.ai/funds/rev1-ventures) — Series A
- Hong Shan — Series B, Series C
- Claremont Creek Ventures (https://capitalatlas.ai/funds/claremont-creek-ventures) — Series B, Series C
- Allos Ventures (https://capitalatlas.ai/funds/allos-ventures) — Series B, Series C
- CincyTech (https://capitalatlas.ai/funds/cincytech) — Series B, Series C
- Mayo Clinic — Series B, Series C
- Cincinnati Children's Hospital Medical Center — Series B, Series C
- Alafi Capital (https://capitalatlas.ai/funds/alafi-capital) — Series C
- Four Rivers Group (https://capitalatlas.ai/funds/four-rivers-group) — Series C
- jVen Capital (https://capitalatlas.ai/funds/jven-capital) — Series C